The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

41 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel conjugates of endoperoxide and 4-anilinoquinazoline as potential anticancer agents.EBI
Soochow University
Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.EBI
Soochow University
4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway.EBI
Soochow University
Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold.EBI
Soochow University
Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.EBI
Soochow University
Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors.EBI
Soochow University
Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors.EBI
Soochow University
Discovery of potent 1H-imidazo[4,5-b]pyridine-based c-Met kinase inhibitors via mechanism-directed structural optimization.EBI
Soochow University
Scaffold hopping approach to a new series of smoothened antagonists.EBI
Soochow University
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.EBI
Soochow University
Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.EBI
Soochow University
Design, synthesis and molecular docking ofa,ß-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.EBI
Soochow University
Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.EBI
Soochow University
Discovery of vinylogous carbamates as a novel class ofß-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.EBI
Soochow University
Discovery of Selective P2YEBI
Soochow University
Aporphines: A privileged scaffold in CNS drug discovery.EBI
Soochow University
Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid.EBI
Soochow University
Investigating the interactions of flavonoids with human OATP2B1: inhibition assay, ICEBI
Soochow University
Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.EBI
Soochow University
Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors.EBI
Soochow University
Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2YEBI
Soochow University
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.EBI
Soochow University
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.EBI
Soochow University
Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family.EBI
Soochow University
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.EBI
Soochow University
Ring closure strategy leads to potent RIPK3 inhibitors.EBI
Soochow University
Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.EBI
Soochow University
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.EBI
Soochow University
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.EBI
Soochow University
Structural optimization of aminopyrimidine-based CXCR4 antagonists.EBI
Soochow University
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.EBI
Soochow University
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.EBI
Soochow University
Structural optimization on a virtual screening hit of smoothened receptor.EBI
Soochow University
Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.EBI
Soochow University
Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.EBI
Soochow University
Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.EBI
Soochow University
Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout.EBI
Soochow University
Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.EBI
Soochow University
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.EBI
Soochow University
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.EBI
Soochow University
P53 activating compoundsBDB
University Court of The University of Dundee